Jacobs Levy Equity Management’s Agios Pharmaceuticals AGIO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$965K	Sell	28,530 -82,620	-74%	-$2.34M	﹤0.01%	714
2025 Q4	$3.03M	Buy	+111,150	New	+$3.9M	0.01%	516
2023 Q3	–	Sell	-144,611	Closed	-$4.1M	–	955
2023 Q2	$4.1M	Sell	144,611 -469,922	-76%	-$11.7M	0.02%	437
2023 Q1	$14.1M	Buy	614,533 +145,787	+31%	+$3.87M	0.09%	236
2022 Q4	$13.2M	Sell	468,746 -17,980	-4%	-$507K	0.09%	245
2022 Q3	$13.8M	Buy	486,726 +89,711	+23%	+$2.41M	0.11%	207
2022 Q2	$8.8M	Sell	397,015 -68,837	-15%	-$1.55M	0.07%	303
2022 Q1	$13.6M	Buy	465,852 +157,811	+51%	+$4.82M	0.09%	242
2021 Q4	$10.1M	Buy	308,041 +5,494	+2%	+$221K	0.07%	302
2021 Q3	$14M	Buy	302,547 +84,525	+39%	+$4.08M	0.09%	242
2021 Q2	$12M	Buy	218,022 +14,746	+7%	+$825K	0.08%	258
2021 Q1	$10.5M	Buy	203,276 +86,690	+74%	+$4.29M	0.08%	287
2020 Q4	$5.05M	Sell	116,586 -19,701	-14%	-$779K	0.04%	396
2020 Q3	$4.77M	Buy	136,287 +92,090	+208%	+$4.04M	0.05%	350
2020 Q2	$2.36M	Buy	+44,197	New	+$2.05M	0.03%	496
2018 Q1	–	Sell	-15,500	Closed	-$886K	–	992
2017 Q4	$886K	Buy	+15,500	New	+$975K	0.02%	640
2016 Q4	–	Sell	-78,537	Closed	-$4.15M	–	951
2016 Q3	$4.15M	Buy	78,537 +45,347	+137%	+$1.97M	0.07%	295
2016 Q2	$1.39M	Buy	+33,190	New	+$1.64M	0.03%	500